Cargando…
Efficacy of a topical formulation containing MIA (Melanoma Inhibitory Activity) ‐ Inhibitory peptides in a case of recalcitrant vitiligo in combination with UV exposure
Vitiligo is an acquired chronic pigmentation disorder of the skin. Even if the role of the immune system seems to be well established, new pathogenetic hypothesis are rising in these years. It has been recently suggested by the development of an animal model that a protein called Melanoma Inhibitory...
Autores principales: | Hernandez Navarro, Sergi, Segura Tejedor, Jordi, Bajona Roig, Marta, Luisetto, Roberto, Fedrigo, Marny, Castellani, Chiara, Angelini, Annalisa, Alaibac, Mauro, Bordignon, Matteo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678623/ https://www.ncbi.nlm.nih.gov/pubmed/36401489 http://dx.doi.org/10.1097/MD.0000000000031833 |
Ejemplares similares
-
Melanoma Inhibitory Activity (MIA) Is Able to Induce Vitiligo-Like Depigmentation in an in vivo Mouse Model by Direct Injection in the Tail
por: Bordignon, Matteo, et al.
Publicado: (2020) -
Discovery of resident memory T cells in inflammatory vitiligo: A case report
por: Xu, YanLi, et al.
Publicado: (2022) -
Identification of key genes and pathways involved in vitiligo development based on integrated analysis
por: Lei, Zixian, et al.
Publicado: (2020) -
Treatment of vitiligo with fire needle: A protocol for systematic review and meta analysis
por: Mingqiang, Liu, et al.
Publicado: (2021) -
Identification of CKS2 and RRM2 as potential markers of vitiligo using bioinformatics analysis
por: Miao, Yu, et al.
Publicado: (2022)